ReviewTranslational andrology and urology2019
Chronic kidney disease after nephrectomy: a clinically-significant entity?
Review in Translational andrology and urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 25 citations in OpenAlex.
- Multiparametric MRI for Predicting Renal Function Deterioration and Chronic Kidney Disease Development in Patients Undergoing Nephrectomy for Renal Masses: A Pilot Study.Journal of magnetic resonance imaging : JMRI · 2026Article
- Clinical risk factors associated with rapid renal function decline after nephrectomy.BMC cancer · 2026Article
- A clinical audit of adverse post-nephrectomy outcomes in renal cell carcinoma patients at a tertiary hospital in Queensland, Australia.Journal of nephrology · 2025Article
- Clear cell likelihood score may improve diagnosis and management of renal masses.Abdominal radiology (New York) · 2024Review
- Risk factors of renal function deterioration after radical nephroureterectomy for upper tract urothelial carcinoma.Frontiers in oncology · 2024Article
- Risk factors and predictive model for acute kidney Injury Transition to acute kidney disease in patients following partial nephrectomy.BMC urology · 2023Article
- New-onset Chronic Kidney Disease After Surgery for Localised Renal Masses in Patients with Two Kidneys and Preserved Renal Function: A Contemporary Multicentre Study.European urology open science · 2023Article
- Kidney failure, CKD progression and mortality after nephrectomy.International urology and nephrology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Worldwide, the kidney is the ninth and 14th most common primary site of cancer in men and women respectively. Surgical management with either radical or partial nephrectomy is the mainstay of treatment. Surgical resection of functional kidney parenchyma is associated with reductions in glomerular filtration rate, and can lead to the development of chronic kidney disease (CKD); however, there is currently debate as to whether CKD secondary to surgical removal of a kidney is of clinical significance. Here, it will be argued that CKD is of clinical significance regardless of aetiology, due to the higher cardiovascular and mortality risk which is associated with low glomerular filtration rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.